Retatrutide is a novel investigational peptide that functions as a triple receptor agonist—targeting GLP-1, GIP, and glucagon receptors. This multifaceted mechanism is being actively studied for its ability to enhance metabolic function, reduce body weight, and improve insulin sensitivity more effectively than single or dual agonists.
Its research relevance is rapidly growing in:
Obesity and weight loss models
Type 2 diabetes and glucose regulation studies
Lipid metabolism and energy expenditure research
Explorations into multi-hormonal metabolic therapies
Product Care:
Store in a cool, dry place away from light. If Constituted, Please Refrigerate. For longer term storage, freezing at -20°C is recommended to maintain integrity.
GLP-3RT (Retatrutide)12MG
GLP-3RT 12MG is a GGG tri-agonist that targets GLP-1 and GIP receptors, akin to standard GLP-1 agonists, but also uniquely activates the glucagon receptor. This extra receptor interaction enhances glucagon production, thereby increasing basal metabolism. Its actions on GLP-1 and GIP receptors promote delayed gastric emptying and appetite control, offering a comprehensive approach to obesity research distinct from older GLP-1 agonists.